| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 29,229 | 21,887 | 27,421 | | Cost of Revenue | 18,275 | 12,788 | 17,287 | | | Gross Profit | 10,954 | 9,099 | 10,134 | | | Operating Expenses | | Research Development | 1,019 | 1,579 | 2,021 | | Selling General and Administrative | 9,198 | 8,435 | 9,865 | | Non Recurring | 61 |
-
| 286 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 676 | (916) | (2,038) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 42 |
-
|
-
| | Earnings Before Interest And Taxes | 718 | (916) | (2,038) | | Interest Expense | 459 | 123 | 257 | | Income Before Tax | 260 | (1,039) | (2,294) | | Income Tax Expense | 20 |
-
| (69) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 240 | (1,039) | (2,225) | | | Non-recurring Events | | Discontinued Operations | (142) | (4,387) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 98 | (5,426) | (2,225) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $98 | ($5,426) | ($2,225) |
|
0.22% Nasdaq 
Income Statement
